StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for LFCR yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-18 | $4.40 | $4.38 | -0.45% | 0.2M |
| 05-19 | $4.32 | $4.38 | +1.39% | 0.2M |
| 05-20 | $4.41 | $4.57 | +3.63% | 0.3M |
| 05-21 | $4.53 | $4.98 | +9.93% | 0.2M |
| 05-22 | $4.98 | $4.93 | -1.00% | 0.2M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $23.19M | $75.52M | $31.11M | $8.66M |
Operating Income | $-4.67M | $-733.00K | $-3.07M | $-590.00K |
Net Income | $-14.98M | $-17.96M | $-9.99M | $-2.86M |
EPS (Diluted) | $-0.43 | $-0.54 | $-0.29 | $-0.09 |
Total Assets | $225.50M | $232.18M | $235.20M | Not available |
Total Liabilities | $204.72M | $198.12M | $198.42M | Not available |
Cash & Equivalents | $20.80M | $17.47M | $18.86M | $20.22M |
Free Cash Flow OCF − CapEx | $3.58M | $3.63M | $25.00K | Not available |
Shares Outstanding | 37.48M | 37.48M | 37.47M | 37.03M |